Pulmonary Drug Delivery: Designed To Deliver Healthier Tomorrows

Pulmonary drug delivery is evolving rapidly, driven by the need for platforms that accelerate development while supporting long‑term product success. This overview highlights how modern inhalation technologies — pMDIs, SMIs, and nebulizers — enable targeted, efficient delivery for both small and large molecules.

Readers will gain clarity on the analytical, formulation, and device‑design considerations essential for bringing respiratory therapies from concept to clinic, including key factors such as solubility, stability, dosing requirements, patient usability, and regulatory pathways. The piece also explores the industry’s shift toward lower‑GWP propellants, offering insight into how greener formulations can support future‑ready product strategies.

Access the full asset to explore device selection guidance, development frameworks, and the capabilities shaping next‑generation inhalation therapies.